Guidelines to Conduct Your Study


Guidelines to conduct your study:


1. For reporting randomized controlled trials authors are advised to consult CONSORT guidelines. Please submit the CONSORT checklist as an additional file and the flowchart as an illustration with the manuscript.

2. The Research protocol can also be submitted on our website separately. However please make sure that you choose the article category properly and that Research Protocols are clearly identified. 


3. If you are submitting a systematic review please follow the PRISMA (formerly QUORUM) guidelines.


4. Please follow STARD guidelines for studies on diagnostic accuracy.




Plagiarism is the use of others’ published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. This applies whether the ideas or words are taken from abstracts, research grant applications, ethics committee applications, or unpublished or published manuscripts in any publication format (print or electronic). Plagiarism is a serious scientific misconduct and WebmedCentral is committed to fight it.  If allegations of plagiarism against an author are proved, we will not only retract the manuscript from our portal but may also bar such authors from publishing again on our portal. Moreover we will maintain a record of such authors and may share it with others in publishing industryand author institutions.. 


Scientific misconduct: 


plus expects the highest level of scientific integrity from its authors. We take issues related to plagiarism, falsification of data, ghost or honorary authorship very seriously. If you have any concerns regarding any article published on plus, please contact us immediately. In such cases, we will initially write to the authors for clarification and may ask them to provide us with additional data. If we are not satisfied with the authors’ response, we may write to authors’ institutions, colleagues, funding bodies and others as appropriate to further investigate. If the allegations are subsequently confirmed, we reserve the right to remove the article from plus. The decision of plus editorial and management team shall be final and binding on authors in such cases. We may also report such authors on our website and share the information with others in the industry.


Authorship Status:


There is now a broad consensus within the scientific community as to what constitutes an acceptable claim for authorship. We discourage both honorary and ghost authorship. Authors will be required to detail the contribution of each author in the study involved and preparation of the manuscript. 


Responding to reviewers:  


We intend to develop a culture of healthy post publication interactions on all published literature on WebmedCentral plus. Scientists and Peers will be able to publish reviews and comments freely post publication on WebmedCentral plus. Authors are encouraged to respond to all reviews or comments posted on their articles.


Withdrawing articles: 


Articles once published cannot be withdrawn by the authors. WebmedCentral plus however reserves the right to retractpapers that are fraudulent, have been plagiarised, are clear examples of scientific misconduct or do not comply with our guidelines. 




Authors will be sent a final version of the article for approval before it is published.   




Due to monetary constraints, we are currently unable to offer copyediting for accepted manuscripts. It is hence the responsibility of the authors to present information in clear, readable, and intelligent English. Our editors may recommend that authors seek help in writing manuscripts if the quality of the language in a manuscript is poor before it can be accepted for publication. 


Ethical considerations: 


plus insists that authors seek approval from relevant ethical committees before conducting human investigations and animal experiments. Such work must have been conducted in keeping with the prevailing local, national and international guidelines for  animal and human experiments. The relevant ethical issues must be clearly mentioned in the manuscript with details of approving body. 


Privacy and Confidentiality: 


We expect our authors and reviewers to respect these issues in line with ICMJE guidelines. Broadly, patients and study subject in human experiments have a right to privacy and reviewers have a duty of confidentiality towards authors. 


Source of Funding and Competing Interests: 


WebmedCentral plus expects all its authors/editors/reviewers to declare their competing interest(s) openly to enable readers to better understand any hidden bias in their statements. Furthermore we expect authors to disclose all source of funding openly during article submission. 


There is a common understanding now within the scientific community as to what constitutes a competing interest. Broadly, an author/reviewer/editor is said to have a competing interest if there is any other (financial or non financial) gain to be had in performance of their routine duties as authors/reviewers/editors apart from what would be expected from the routine pursuit of such academic activities. A competing interest exists when your professional judgement may be influenced by any other interest in the publication of an article/review/comment on WebmedCentral plus. This other interest may constitute financial gains, share holding in a company that manufactures the drug or device under study, grants, professional rivalry or personal beliefs. Essentially it arises when authors/editors/reviewers have an interest that may influence, with or without their knowledge, their interpretation and presentation of scientific material. We believe that our authors/editors/reviewers/commentators should make these interests clear before publishing/posting any content on our web portals. 


Data Sharing: 


WebmedCentral plus encourages authors to share their raw data as much as possible with others in the scientific community. With the use of information technology, it is now possible for authors to share data and information in a way that was not possible in the past. 




We expect our speciality editors, editorial board members, and reviewers to treat all manuscripts, information, and data in strict confidence.